Paul Gallagher, Vice President US Market Access Strategy at Certara, brings over 40 years of healthcare leadership that is characterized by its breadth and extensive experience in the development and commercialization of life science innovations.
Before founding a consulting company in 1994, that specialized in development of evidence-based value and access strategies, Paul worked for legacy companies of Novartis (Ciba-Geigy), Sanofi (Merrell Dow) and Pfizer (Wyeth), holding positions of increasing responsibilities in marketing research, product management, sales management and executive commercial management, including Vice President of Global Marketing.
Paul holds a BA in economics from Columbia University and an MBA in marketing from George Washington University.
He has been a member of the Faculty of the Drug Development Boot Camp at Harvard University from 2011 through 2016, moderated a panel on Commercialization and Reimbursement of Gene Therapies at the Genetic Rx Conference, and been a Panelist on What’s Hot & What’s Not in Gene Therapies for Rare Disorders, Webinar sponsored by BIO.
In May 2017, he presented the results of a survey of 21 US payers to fuel a discussion at the ISPOR International Meeting by noted US and UK payers on A Comparative US-UK Perspective to Debate the Role of the US Health System in the Development and Implementation of Value Frameworks.